UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Nanosuspensions in drug delivery

Nature reviews. Drug discovery, 2004-09, Vol.3 (9), p.785-796

Rabinow, Barrett E

2004

Volltextzugriff (PDF)

Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles

PloS one, 2009-02, Vol.4 (2), p.e4343

2009

Volltextzugriff (PDF)

Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects

Advanced drug delivery reviews, 2008-05, Vol.60 (8), p.939-954

2008

Volltextzugriff (PDF)

Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS

The Journal of immunology (1950), 2009-07, Vol.183 (1), p.661-669

2009

Volltextzugriff (PDF)

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

Blood, 2006-10, Vol.108 (8), p.2827-2835

2006

Volltextzugriff (PDF)

Nanotechnology: a focus on nanoparticles as a drug delivery system

Journal of neuroimmune pharmacology, 2006-09, Vol.1 (3), p.340-350

2006

Volltextzugriff (PDF)

Proper Accounting for Surface Area to Solution Volume Ratios in Exaggerated Extractions

PDA journal of pharmaceutical science and technology, 2017-05, Vol.71 (3), p.225

2017

Volltextzugriff (PDF)

Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages

Virology (New York, N.Y.), 2007-02, Vol.358 (1), p.148-158

2007

Volltextzugriff (PDF)

An Enantiomerically Pure Formulation of Esmolol Attenuates Hypotension and Preserves Heart Rate Control in Dogs

Anesthesiology (Philadelphia), 2014-12, Vol.121 (6), p.1184-1193

2014

Volltextzugriff (PDF)

Ingress of blood-borne macrophages across the blood-brain barrier in murine HIV-1 encephalitis

Journal of neuroimmunology, 2008-08, Vol.200 (1), p.41-52

2008

Volltextzugriff (PDF)

An enantiomerically pure formulation of esmolol attenuates hypotension and preserves heart rate control in dogs

Journal of pharmacological and toxicological methods, 2015-09, Vol.75, p.186-186

2015

Volltextzugriff (PDF)

Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat

International journal of pharmaceutics, 2007-07, Vol.339 (1), p.251-260

2007

Volltextzugriff (PDF)

Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS Therapeutics

Journal of neuroimmune pharmacology, 2010-12, Vol.5 (4), p.592-601

2010

Volltextzugriff (PDF)

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-–macrophage drug delivery

Nanomedicine (London, England), 2009-12, Vol.4 (8), p.903-917

2009

Volltextzugriff (PDF)

Intra-articular (IA) Ropivacaine Microparticle Suspensions Reduce Pain, Inflammation, Cytokine, and Substance P Levels Significantly More than Oral or IA Celecoxib in a Rat Model of Arthritis

Inflammation, 2015-02, Vol.38 (1), p.40-60

2015

Volltextzugriff (PDF)

Paclitaxel nanosuspensions for targeted chemotherapy - nanosuspension preparation, characterization, and use

Pharmaceutical development and technology, 2014-06, Vol.19 (4), p.438-453

2014

Volltextzugriff (PDF)

Nanosuspension Formulation of Itraconazole Eliminates the Negative Inotropic Effect of SPORANOX® in Dogs

Journal of medical toxicology, 2010-09, Vol.6 (3), p.331-336

2010

Volltextzugriff (PDF)

Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage

Nanotoxicology, 2011-12, Vol.5 (4), p.592-605

2011

Volltextzugriff (PDF)

NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppm : Heparin Characterization

Analytical and bioanalytical chemistry, 2011, Vol.399 (2), p.651-662

2011

Volltextzugriff (PDF)

NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppm

Analytical and bioanalytical chemistry, 2011-01, Vol.399 (2), p.651-662

2011

Volltextzugriff (PDF)

Suspensions for intravenous (IV) injection : A review of development, preclinical and clinical aspects: Clinical Developments in Drug Delivery Nanotechnology

Advanced drug delivery reviews, 2008, Vol.60 (8), p.939-954

2008

Volltextzugriff (PDF)

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS1

The Journal of immunology (1950), 2009-06, Vol.183 (1), p.661-669

2009

Volltextzugriff (PDF)

Nanoformulated Antiretroviral Combinations Extend Drug Release and Antiretroviral Responses in HIV-1 Infected Macrophages: Implications for NeuroAIDS Therapeutics

Journal of neuroimmune pharmacology, 2010-03, Vol.5 (4), p.592-601

2010

Volltextzugriff (PDF)

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Commentary

Blood, 2006, Vol.108 (8)

2006

Volltextzugriff (PDF)

Model for estimating the accumulation of solutes leaching from polymeric containers into parenteral solutions

International journal of pharmaceutics, 1992-01, Vol.78 (1), p.115-122

1992

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)
Dissertationen
(1)

Sprache

Englisch
(29)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Animals
(12)
Humans
(11)
Pharmacology & Pharmacy
(9)
Biological And Medical Sciences
(7)
Male
(7)
Medical Sciences
(7)
Cells, Cultured
(6)
Nanoparticles
(6)
Pharmacology. Drug Treatments
(6)
Drug Delivery Systems
(5)
General Pharmacology
(5)
Immunology
(5)
Macrophages - Metabolism
(5)
Mice
(5)
Pharmaceutical Technology. Pharmaceutical Industry
(5)
Chemistry, Pharmaceutical
(4)
Indinavir - Pharmacokinetics
(4)
Macrophages - Virology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nanosuspensions in drug delivery

Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles

Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects

Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

Nanotechnology: a focus on nanoparticles as a drug delivery system

Proper Accounting for Surface Area to Solution Volume Ratios in Exaggerated Extractions

Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages

An Enantiomerically Pure Formulation of Esmolol Attenuates Hypotension and Preserves Heart Rate Control in Dogs

Ingress of blood-borne macrophages across the blood-brain barrier in murine HIV-1 encephalitis

An enantiomerically pure formulation of esmolol attenuates hypotension and preserves heart rate control in dogs

Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat

Nanoformulated Antiretroviral Drug Combinations Extend Drug Release and Antiretroviral Responses in HIV-1-Infected Macrophages: Implications for NeuroAIDS Therapeutics

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-–macrophage drug delivery

Intra-articular (IA) Ropivacaine Microparticle Suspensions Reduce Pain, Inflammation, Cytokine, and Substance P Levels Significantly More than Oral or IA Celecoxib in a Rat Model of Arthritis

Paclitaxel nanosuspensions for targeted chemotherapy - nanosuspension preparation, characterization, and use

Nanosuspension Formulation of Itraconazole Eliminates the Negative Inotropic Effect of SPORANOX® in Dogs

Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage

NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppm : Heparin Characterization

NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppm

Suspensions for intravenous (IV) injection : A review of development, preclinical and clinical aspects: Clinical Developments in Drug Delivery Nanotechnology

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS1

Nanoformulated Antiretroviral Combinations Extend Drug Release and Antiretroviral Responses in HIV-1 Infected Macrophages: Implications for NeuroAIDS Therapeutics

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Commentary

Model for estimating the accumulation of solutes leaching from polymeric containers into parenteral solutions

Suchergebnisse filtern